The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases

Publisher Website

5 October 2020

journal article
editorial
Published by Elsevier BV in Vaccine

Vol. 38 (46), 7198-7200
https://doi.org/10.1016/j.vaccine.2020.09.057

Abstract

No abstract available

This publication has 1 reference indexed in Scilit:

Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens
npj Vaccines, 2020

Cited by 1 article